Fundraising FoxMirati Therapeutics
5 known investors
Find your way into Mirati Therapeutics
Sign up to see every warm intro you have to Mirati Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mirati Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.
Investors · 5
Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
Boxer Capital, LLClisted by Boxer Capital, LLCSan Diego
How we know: Boxer Capital, LLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Mirati Therapeutics do?
- Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.
- Who are Mirati Therapeutics's investors?
- Mirati Therapeutics's investors include Avoro Capital Advisors, BioBrit, Boxer Capital, LLC, Nextech Invest, Pappas Capital.